JOANNA NGUYEN: Open Payments
NPI 1962808915 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,326 in 217 payments from 20 companies in 2025. Trend: 2023 $3,744 · 2024 $4,886 · 2025 $5,326
Food & beverage: $5,137Education: $190
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 24 | $666 |
| GENZYME CORPORATION | 17 | $606 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 26 | $539 |
| Janssen Biotech, Inc. | 19 | $526 |
| ABBVIE INC. | 30 | $500 |
| PFIZER INC. | 21 | $409 |
| Arcutis Biotherapeutics, Inc. | 17 | $406 |
| Regeneron Healthcare Solutions, Inc. | 10 | $391 |
| Lilly USA, LLC | 7 | $255 |
| Incyte Corporation | 13 | $226 |
Products named: DUPIXENT, TREMFYA, Bimzelx, Winlevi, Zoryve, CIBINQO, SKYRIZI, OPZELURA.
Industry payments across WA — which companies pay providers there.
